As new parents, we all know how precious sleep is for both our little ones and ourselves. But what happens when your newborn starts jerking their limbs uncontrollably while they’re sleeping? Don’t panic! It might be a case of benign neonatal sleep myoclonus (BNSM). In this blog post, we’ll dive into the causes and symptoms of BNSM to help you understand why it’s happening and what steps you can take to ensure your baby gets the rest they need.
Benign neonatal sleep myoclonus is a condition that affects newborn babies. It is characterized by brief, jerky movements of the arms and legs during sleep. Benign neonatal sleep myoclonus is harmless and usually goes away on its own within a few weeks. In some cases, it may persist into infancy or early childhood. There is no known cause for benign neonatal sleep myoclonus, but it is believed to be related to the immaturity of the infant nervous system.
The most common cause of benign neonatal sleep myoclonus is an immature nervous system. The condition is also seen occasionally in premature babies, who have an even more immature nervous system. Benign neonatal sleep myoclonus usually goes away on its own as the baby's nervous system matures.
There are a number of other potential causes of benign neonatal sleep myoclonus, including:
• Inherited disorders: There are a few rare inherited disorders that can cause myoclonic jerks in infancy. One example is Ohtahara syndrome, which is caused by a mutation in a gene involved in the development of the central nervous system.
• Metabolic disorders: In some cases, myoclonic jerks may be a sign of an underlying metabolic disorder such as hypoglycemia (low blood sugar) or hypocalcemia (low blood calcium).
• Infections: Rarely, an infection such as meningitis or encephalitis can cause myoclonic jerks.
• Drugs or toxins: Myoclonic jerks can also be a side effect of certain drugs or toxins, such as withdrawal from alcohol or barbiturates.
When an infant is born, they typically experience a variety of new sensations and movements. One of these movements is called benign neonatal sleep myoclonus, which is a normal, harmless reflex that can occur during sleep.
While the exact cause of benign neonatal sleep myoclonus is unknown, it is thought to be related to the immature nervous system. When an infant experiences this reflex, they may make jerky movements or twitchings while asleep. These movements are usually brief and do not cause any discomfort or distress to the baby.
Benign neonatal sleep myoclonus is considered a normal part of an infant's development and typically does not require any treatment. In most cases, the reflex will resolve on its own as the nervous system matures. However, if your infant continues to experience these jerky movements or twitches beyond six months of age, it is important to speak with your pediatrician as this may be indicative of a more serious underlying condition.
While the cause of benign neonatal sleep myoclonus is unknown, there are a few potential treatments that may help lessen the frequency and severity of myoclonic jerks. One such treatment is the use of anticonvulsant medications, which have been shown to be effective in reducing myoclonus in some infants.
Another potential treatment option for benign neonatal sleep myoclonus is physiotherapy. This involves exercises that help to stretch and strengthen the muscles affected by myoclonus. Physiotherapy can also help improve coordination and balance, which may be affected by myoclonus.
DBS involves implanting electrodes into the brain to deliver electrical stimulation to specific areas that control muscle movement. While DBS has been found to be effective in treating various movement disorders, its long-term safety and efficacy in infants with benign neonatal sleep myoclonus is not yet known.
Understanding the causes and symptoms of benign neonatal sleep myoclonus is essential for parents in order to ensure their child’s comfort and safety. Although there is no cure for the disorder, with early detection and proper treatment, babies can go on to develop normally and lead healthy lives. By having an understanding of this condition, parents can be better equipped to recognize its signs and treat it quickly in order to prevent any long-term complications.
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation